Antitrust litigation filed against Dr Reddy’s Lab and others

Dr. Reddy's Laboratories Ltd. asserted that "the allegations against it lack merit and it will vigorously defend the litigation."

336
Medicine
Picture: Pixabay

Last Updated on November 24, 2022 by The Health Master

New Delhi: Dr. Reddy’s Laboratories Ltd. said it is among several generic pharmaceutical companies, including Celgene and Bristol Myers Squibb, against which antitrust litigation has been filed in the US.

In a regulatory filing, the company said a complaint was filed on November 18, 2022, in the District of New Jersey, USA, and it along with other generic pharmaceutical firms, has been named as the defendant.

“The complaint, which purports to be on behalf of a class of indirect purchasers, asserts claims under federal and state antitrust laws and other state laws, alleging that the defendants improperly restrained competition and maintained a shared monopoly in the sale of the brand- and generic Revlimid through their respective settlements of patent litigation,” Dr. Reddy’s Laboratories said.

Revlimid is a prescription medicine, used to treat adults with multiple myeloma (MM) in combination with dexamethasone, or as maintenance treatment after a type of stem cell transplant that uses an individual’s own stem cells.

The company said the complaint “alleges that the challenged agreements improperly delayed generic entry entirely until 2022 and then improperly limited generic competition through 2026.”

The complaint seeks damages for purported overpayments and equitable relief, it added.

Dr. Reddy’s asserted that “the allegations against it lack merit and it will vigorously defend the litigation.”

GSK to stop selling this Blood Cancer drug

USFDA gives nod for Nifedipine ER tablets

NPPA: No bar on taking corrective measures if some error occurs

RIICO to develop Medical Devices Park

USFDA gives nod for Amphotericin B Liposome Injection

USFDA issues Form 483 with 10 observations to Aurobindo Pharma

USFDA gives approval for Potassium-deficiency drug

Govt starts drive against misuse of Antibiotics

Bar code or QR code for 300 brands: Govt notifies these drugs under Schedule H2

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news